Virax Biolabs Group Limited (NASDAQ:VRAX) Financings
Financings
| Raise | Date |
|---|---|
| Ordinary shares on exercise of preferred investment options Closed: US$3.3M in the latest tranche · US$6 a share · Warrants at US$6 · H.C. Wainwright & Co. Dealers: H.C. Wainwright & Co. (lead) Use of proceeds: Working capital for general corporate purposes | Jul 16, 2026 |
| Private placement of ordinary shares (or pre-funded warrants) and preferred investment options Closed: US$5M raised · US$0.3999 a share · Warrants at US$0.4 for 60 months · H.C. Wainwright & Co. Dealers: H.C. Wainwright & Co. (lead) Use of proceeds: General working capital, extending cash runway into the first half of 2028 | Dec 4, 2025 |